We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+4.87%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$102B
AUM Growth
+$1.43B
(+1.4%)
Cap. Flow
-$1.09B
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
32.54%
Holding
287
New
14
Increased
80
Reduced
134
Closed
11
Avg Time Held
2.7
years
Top 10 Avg Time Held
3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qiagen
QGEN
|
+$518M |
| 2 |
AstraZeneca
AZN
|
+$246M |
| 3 |
Alkermes
ALKS
|
+$172M |
| 4 |
Whirlpool
WHR
|
+$94.4M |
| 5 |
Eli Lilly
LLY
|
+$78.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
QGENF
QIAGEN NV
QGENF
|
+$534M |
| 2 |
Charles Schwab
SCHW
|
+$265M |
| 3 |
Amgen
AMGN
|
+$235M |
| 4 |
NVIDIA
NVDA
|
+$233M |
| 5 |
Microsoft
MSFT
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.82% |
| 2 | Healthcare | 22.95% |
| 3 | Industrials | 16.78% |
| 4 | Consumer Discretionary | 9.51% |
| 5 | Financials | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CVA
251
DELISTED
Covanta Holding Corporation
CVA
| $2.65M | ﹤0.01% |
170,000
| – | – |
2015 Q4
4 quarters
|
|
252
Greif Class B
GEF.B
$4.18B
| $2.5M | ﹤0.01% |
37,000
| – | – |
2013 Q2
14 quarters
|
|
253
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $2.33M | ﹤0.01% |
73,000
-1,000
| -1% | -$32K |
2015 Q3
5 quarters
|
|
|
FRAN
254
DELISTED
Francesca's Holdings Corporation
FRAN
| $2.26M | ﹤0.01% |
10,442
| – | – |
2015 Q2
6 quarters
|
|
255
AdvanSix
ASIX
$446M
| $2.16M | ﹤0.01% |
+97,667
| New | +$1.75M |
2016 Q4
0 quarters
|
|
256
Armstrong World Industries
AWI
$7.04B
| $1.88M | ﹤0.01% |
+45,000
| New | +$1.84M |
2016 Q4
0 quarters
|
|
257
Controladora Vuela Compania de Aviacion
VLRS
$689M
| $1.83M | ﹤0.01% |
122,000
| – | – |
2013 Q4
12 quarters
|
|
258
DELISTED
Skechers
SKX
| $1.79M | ﹤0.01% |
+73,000
| New | +$1.68M |
2016 Q4
0 quarters
|
|
|
REXX
259
DELISTED
Rex Energy Corporation
REXX
| $1.54M | ﹤0.01% |
327,500
-37,000
| -10% | -$178K |
2013 Q2
14 quarters
|
|
260
DELISTED
Adverum Biotechnologies
ADVM
| $1.23M | ﹤0.01% |
42,560
-70
| -0.2% | -$2.29K |
2014 Q3
9 quarters
|
|
261
McDonald's
MCD
$172B
| $1.22M | ﹤0.01% |
10,000
| – | – |
2016 Q1
3 quarters
|
|
|
CERN
262
DELISTED
Cerner Corp
CERN
| $947K | ﹤0.01% |
20,000
| – | – |
2013 Q2
14 quarters
|
|
263
Post Holdings
POST
$3.51B
| $884K | ﹤0.01% |
16,808
-1,528
| -8% | -$77.2K |
2014 Q3
9 quarters
|
|
264
Expro Ltd
XPRO
$1.76B
| $872K | ﹤0.01% |
11,800
-18,333
| -61% | -$1.34M |
2013 Q3
13 quarters
|
|
265
Ollie's Bargain Outlet
OLLI
$5.68B
| $677K | ﹤0.01% |
23,800
-117,800
| -83% | -$3.4M |
2015 Q3
5 quarters
|
|
266
Workday
WDAY
$47.4B
| $661K | ﹤0.01% |
10,000
| – | – |
2013 Q2
14 quarters
|
|
|
DXTR
267
DELISTED
Dextera Surgical Inc.
DXTR
| $576K | ﹤0.01% |
600,450
-900
| -0.1% | -$1.35K |
2016 Q2
2 quarters
|
|
268
Arista Networks
ANET
$234B
| $329K | ﹤0.01% |
54,400
-78,400
| -59% | -$439K |
2014 Q2
10 quarters
|
|
269
A10 Networks
ATEN
$1.84B
| – | – |
-35,000
| Closed | -$374K | – |
|
270
F5
FFIV
$25.9B
| – | – |
-120,275
| Closed | -$15M | – |
|
271
Petrobras
PBR
$163B
| – | – |
-421,100
| Closed | -$3.93M | – |
|
272
Petrobras Class A
PBR.A
$146B
| – | – |
-681,600
| Closed | -$5.66M | – |
|
273
Twilio
TWLO
$42B
| – | – |
-3,900
| Closed | -$251K | – |
|
|
CBI
274
DELISTED
Chicago Bridge & Iron Nv
CBI
| – | – |
-120,000
| Closed | -$3.36M | – |
|
|
CAB
275
DELISTED
Cabela's Inc
CAB
| – | – |
-23,000
| Closed | -$1.26M | – |
|
Similar funds
Primecap Management's Q4 2016 Portfolio in Review
As of Q4 2016, Primecap Management held 287 positions worth $102B, up 1.4% from $100B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management's Q4 2016 filing shows 14 new, 80 increased, 134 reduced and 11 closed positions. Its largest new stake was Qiagen: 17,384,319 shares worth $536M. The largest sale was QIAGEN NV, an estimated $534M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q4 2016 buy was Qiagen: 17,384,319 shares worth $536M.
- Primecap Management added most to AstraZeneca in Q4 2016, an estimated $246M increase.
- Primecap Management's biggest Q4 2016 reduction was Charles Schwab, cutting an estimated $265M.
- Primecap Management fully exited QIAGEN NV in Q4 2016, selling an estimated $534M.
- Primecap Management's ten largest holdings make up 33% of its $102B portfolio in Q4 2016.
- Primecap Management opened 14 new positions and closed 11 in Q4 2016.
- Primecap Management's portfolio value rose 1.4% quarter-over-quarter to $102B.
Based on Primecap Management's 13F filing for Q4 2016, filed 13 Feb 2017.